Pith. sign in

REVIEW 2 major objections 1 minor 18 references

BreastGPT, trained on a 1.86M-pair workflow dataset, outperforms other MLLMs with 75.66% closed-ended accuracy on breast cancer benchmark.

Reviewed by Pith at T0; open to challenge. T0 means a machine referee read the full paper against a public rubric. the ladder, T0–T4 →

T0 review · grok-4.3

2026-06-28 06:35 UTC pith:FW3OVREE

load-bearing objection New 1.86M breast cancer instruction corpus and dual-branch encoder are concrete additions, but the internal benchmark does not yet establish clinical workflow utility. the 2 major comments →

arxiv 2606.04911 v1 pith:FW3OVREE submitted 2026-06-03 cs.CV cs.CL

BreastGPT: A Multimodal Large Language Model for the Full Spectrum of Breast Cancer Clinical Routine

classification cs.CV cs.CL
keywords breast cancermultimodal large language modelmedical imagingclinical workflowinstruction corpuspathologyradiologybenchmark
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

Breast cancer management spans screening, diagnosis, and treatment, each using different imaging and reasoning demands, yet existing medical multimodal models are typically tested on narrow slices of this process. The paper assembles BreastStage, a large instruction corpus drawn from 17 sub-datasets across five modalities and 136 task templates, then trains BreastGPT with a dual-branch visual encoder and token compression to handle both ordinary radiology scans and gigapixel pathology slides. On the held-out BreastStage-Bench the model records 75.66% closed-ended accuracy and 89.92% open-ended score, beating both general-purpose and medical-specific MLLMs across stages and formats. The authors conclude that aligning training data to the actual clinical workflow and modeling cross-scale images are essential for usable medical multimodal systems. They release the corpus, benchmark, code, and checkpoints.

Core claim

BreastGPT is a unified multimodal large language model equipped with a dual-branch visual encoder and concept-preserving token compression; trained on the BreastStage corpus of 1.86 million workflow-aligned instruction pairs, it reaches 75.66% closed-ended accuracy and 89.92% open-ended score on BreastStage-Bench, outperforming prior general and medical MLLMs across the screening-to-treatment continuum.

What carries the argument

The BreastStage instruction corpus (1.86M pairs, 17 sub-datasets, 5 modalities, 136 templates) together with BreastGPT's dual-branch visual encoder and concept-preserving token compression for cross-scale radiology-to-pathology modeling.

Load-bearing premise

The held-out BreastStage-Bench and its 136 task templates provide a valid proxy for clinically grounded multimodal reasoning across the full breast cancer care continuum.

What would settle it

If another model trained without the workflow-aligned corpus or the dual-branch encoder matches or exceeds BreastGPT's scores on BreastStage-Bench, the necessity of those two components would be challenged.

Watch this falsifier — get emailed when new claim-graph text bears on it.

If this is right

  • Workflow-aligned instruction data enables a single model to perform multimodal reasoning across screening, diagnosis, and treatment planning.
  • Dual-branch visual encoding plus token compression can bridge the resolution gap between standard radiology and gigapixel pathology images.
  • Models built this way outperform both general-purpose and medical-specific MLLMs on the same clinical tasks.
  • Releasing the full corpus, benchmark, code, and checkpoints allows other groups to build on the same workflow foundation.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The same workflow-alignment strategy could be applied to construct comparable corpora and models for other cancers or chronic diseases with multi-stage care paths.
  • The dual-branch encoder design may transfer to other medical domains that combine low-resolution overview images with high-resolution detail slides.
  • If the benchmark correlates with downstream clinical utility, the released model could serve as a starting point for hospital-specific fine-tuning.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

2 major / 1 minor

Summary. The manuscript introduces BreastStage, a workflow-aligned breast imaging instruction corpus with 1.86M pairs curated from 17 sub-datasets across 5 modalities using 136 task templates spanning screening, diagnosis, and treatment planning. It presents BreastGPT, an MLLM with a dual-branch visual encoder and concept-preserving token compression to handle radiology-to-pathology scale gaps. On the held-out BreastStage-Bench, the model reports 75.66% closed-ended accuracy and 89.92% open-ended score, outperforming general-purpose and medical MLLMs, with the conclusion that workflow-aligned data and cross-scale modeling are critical for clinically grounded medical MLLMs. All data, code, and checkpoints are released.

Significance. If the benchmark is shown to be a valid proxy, the work would advance multimodal reasoning models for the full breast cancer care continuum and highlight the role of large-scale, multi-stage instruction data. The public release of resources is a clear strength supporting reproducibility.

major comments (2)
  1. [Dataset and Benchmark Construction] Benchmark construction (dataset section): The central outperformance claim (75.66% / 89.92%) is interpreted as evidence that workflow-aligned data and cross-scale modeling yield clinically grounded MLLMs, yet the manuscript supplies no external clinician review, correlation with clinical decision logs/outcomes, or quantification of how the 136 templates capture reasoning variability and edge cases across the care continuum; this assumption is load-bearing for the clinical proxy interpretation.
  2. [Results and Evaluation] Evaluation protocol (results section): The concrete accuracy figures and outperformance statements across clinical stages and task formats are presented without reported details on statistical testing, run-to-run variance, baseline hyperparameter matching, or data exclusion criteria, which is required to substantiate robustness of the held-out split results.
minor comments (1)
  1. [Abstract] The abstract states the URL for released resources but the main text could more explicitly cross-reference the exact repository contents (e.g., which sub-datasets are included in the 1.86M pairs).

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive feedback on our manuscript. We address each major comment below and describe the planned revisions to improve clarity and robustness.

read point-by-point responses
  1. Referee: [Dataset and Benchmark Construction] Benchmark construction (dataset section): The central outperformance claim (75.66% / 89.92%) is interpreted as evidence that workflow-aligned data and cross-scale modeling yield clinically grounded MLLMs, yet the manuscript supplies no external clinician review, correlation with clinical decision logs/outcomes, or quantification of how the 136 templates capture reasoning variability and edge cases across the care continuum; this assumption is load-bearing for the clinical proxy interpretation.

    Authors: We acknowledge that the manuscript does not include external clinician review, correlation with clinical outcomes, or explicit quantification of template coverage for edge cases. The 136 templates were manually designed by the authors based on standard breast cancer clinical guidelines to span screening, diagnosis, and treatment planning across modalities. The outperformance figures are strictly on the held-out BreastStage-Bench split. We agree this limits the strength of any 'clinically grounded' interpretation. In revision we will (i) rephrase the abstract, discussion, and conclusion to present the results as performance on a workflow-aligned benchmark rather than direct evidence of clinical grounding, and (ii) add an explicit limitations paragraph discussing the absence of clinician validation and the value of future studies using the released resources. revision: yes

  2. Referee: [Results and Evaluation] Evaluation protocol (results section): The concrete accuracy figures and outperformance statements across clinical stages and task formats are presented without reported details on statistical testing, run-to-run variance, baseline hyperparameter matching, or data exclusion criteria, which is required to substantiate robustness of the held-out split results.

    Authors: We agree that these evaluation details are necessary. The current manuscript reports single-run results on the held-out split without variance estimates or formal significance tests. In the revised manuscript we will add: (1) accuracy and open-ended scores averaged over three random seeds with standard deviations, (2) statistical significance tests (McNemar’s test for closed-ended accuracy and paired t-tests for open-ended scores) against all baselines, (3) a table or section detailing hyperparameter configurations used for each baseline to confirm matching, and (4) explicit description of the data exclusion criteria and splitting procedure used to create BreastStage-Bench. These will appear in the results section and supplementary material. revision: yes

Circularity Check

0 steps flagged

No significant circularity; empirical results on held-out benchmark

full rationale

The paper's central claims consist of empirical performance numbers (75.66% closed-ended, 89.92% open-ended) measured on an explicitly held-out split of the newly introduced BreastStage-Bench. No equations, derivations, or 'predictions' are presented that reduce to fitted parameters or self-definitions by construction. The model architecture (dual-branch encoder, token compression) is described as a design choice, not derived from the benchmark results. The suggestion that 'workflow-aligned data and cross-scale visual modeling are critical' is an interpretation of the empirical comparison, not a tautological restatement of inputs. No self-citation chains or uniqueness theorems are invoked as load-bearing premises. The held-out split and release of data/code provide external falsifiability, keeping the derivation self-contained.

Axiom & Free-Parameter Ledger

1 free parameters · 1 axioms · 0 invented entities

The central performance claim rests on the representativeness of the curated instruction pairs and the assumption that benchmark scores translate to clinical utility; no free parameters are explicitly fitted to the target result in the abstract, and no new physical entities are postulated.

free parameters (1)
  • training hyperparameters and token compression ratio
    Standard LLM training choices that affect final performance but are not detailed in the abstract.
axioms (1)
  • domain assumption The 136 task templates and 17 sub-datasets accurately capture real clinical reasoning patterns across screening, diagnosis, and treatment planning.
    The claim that workflow-aligned data is critical depends on this premise about the corpus quality.

pith-pipeline@v0.9.1-grok · 5844 in / 1433 out tokens · 35880 ms · 2026-06-28T06:35:34.661628+00:00 · methodology

0 comments
read the original abstract

Breast cancer remains a leading cause of cancer-related mortality among women. Its clinical management requires multimodal reasoning across a clinical workflow that spans \textit{screening}, \textit{diagnosis} and \textit{treatment planning}, where each stage involves distinct imaging modalities, task objectives, and reasoning patterns. However, constrained by data scarcity and model versatility, existing medical MLLMs are typically evaluated on isolated modalities or narrow task families, limiting their ability to support workflow-level clinical reasoning. In this work, we first introduce \textbf{BreastStage}, a workflow-aligned breast imaging instruction corpus comprising 1.86M instruction-following pairs curated from 17 sub-datasets across 5 imaging modalities and 136 task templates. Its held-out split, \textbf{BreastStage-Bench}, provides a comprehensive benchmark for evaluating multimodal reasoning across the breast cancer care continuum. Building on this corpus, we propose \textbf{BreastGPT}, a unified MLLM equipped with a dual-branch visual encoder and concept-preserving token compression to bridge the scale gap between standard radiology and gigapixel pathology. On BreastStage-Bench, BreastGPT achieves 75.66\% closed-ended accuracy and 89.92\% open-ended score, outperforming both general-purpose and medical-specific MLLMs across clinical stages and task formats. These results suggest that workflow-aligned data and cross-scale visual modeling are critical for clinically grounded medical MLLMs. All data, code, and model checkpoints are released at https://yangyy-liu.github.io/BreastGPT.io.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

18 extracted references · 2 canonical work pages

  1. [1]

    Unique 2D / 3D images

    Kaggle. Junying Chen, Chi Gui, Ruyi Ouyang, Anningzhe Gao, Shunian Chen, Guiming Hardy Chen, Xidong Wang, Ruifei Zhang, Zhenyang Cai, Ke Ji, et al. Huatuogpt-vision, towards injecting medical visual knowledge into multimodal llms at scale.arXiv preprint arXiv:2406.19280, 2024a. Pengcheng Chen, Jin Ye, Guoan Wang, Yanjun Li, Zhongying Deng, Wei Li, Tianbin...

  2. [2]

    TheQuestionmustbe open-ended and descriptive: donotask yes/no questions, donotinclude options or binary choices

  3. [3]

    The Answer mustbe a complete sentence that is strictly based on the providedAnswer value, and doesnotintroduce any new medical interpretation, diagnosis, or inference

  4. [4]

    Donotintroduce information not explicitly contained in the input

  5. [5]

    Donotrepeat or list the provided options in the output

  6. [6]

    Use varied sentence structures across different samples

  7. [7]

    Use precise anatomical and imaging terminology appropriate for breast{modality}

  8. [8]

    Question

    Outputonlyvalid JSON in the specified format. No extra text. Input (JSON):{"Question": "...", "options": ["...","...","..."], "Answer": "..."}. Output (JSON):{"Question": "...", "Answer": "..."}. Grounded Caption Generator You are anexpert Radiologist Assistantproducing aGrounded Captionfor breast {modality}. Strictly separatevisual attributes(shape, marg...

  9. [9]

    • Convex/Sector Probe (Fan-shaped Field):WARNING– typical for Abdomen/Liver

    Modality & Probe Geometry (BREAST FOCUS): • Linear Probe (Rectangular Field):high probability of valid Breast US. • Convex/Sector Probe (Fan-shaped Field):WARNING– typical for Abdomen/Liver. Mark Valid only if the text explicitly confirms a deep breast mass. •Modality:confirm Ultrasound (speckle texture)

  10. [10]

    •Focus zone:aligned with the mammary layer

    Image Quality & Settings: • Depth: < 4–6cm; reject if deep abdominal structures (liver / kidney) are visible. •Focus zone:aligned with the mammary layer. •Gain:fat / glandular interface distinguishable

  11. [11]

    Liver”, “Gall- bladder

    Text–Image Alignment:flag if the text mentions “Liver”, “Gall- bladder”, or “Thyroid”. Output JSON:{validity: Valid/Invalid, reason}. Mammography Quality Selector You are aMammography Quality Control Expert. Validate if the image is a diagnosticMammogram (MG). Evaluate the following:

  12. [12]

    • STRICTL Y REJECTChest X-Ray (CXR): if you see ribs, lungs, clavicles, or the spine, mark Invalid

    Modality Distinction (CRITICAL): • Confirm Mammogram: soft-tissue breast against black air background. • STRICTL Y REJECTChest X-Ray (CXR): if you see ribs, lungs, clavicles, or the spine, mark Invalid

  13. [13]

    Implant Displaced (Eklund)

    Breast-Specific Positioning (PGMI Criteria): • Pectoralis muscle:for MLO views, must extend to the nipple line. • Nipple profile:in profile (not superimposed) unless retracted. • Skin folds:reject severe folds that mimic abnormalities. • Implants:identify “Implant Displaced (Eklund)” views vs. standard views

  14. [14]

    fibroglandular tissue (white) must be distinguishable; reject motion blur at calcifications

    Exposure & Contrast:adipose (dark gray) vs. fibroglandular tissue (white) must be distinguishable; reject motion blur at calcifications

  15. [15]

    Output JSON:{validity, reason}

    Text–Image Alignment:text describes mammographic findings (asymmetry, distortion, calcification). Output JSON:{validity, reason}. Breast MRI Quality Selector You are aBreast MRI Physics Specialist. Validate if the image is a diagnosticBreast MRIsequence. Evaluate the following:

  16. [16]

    • Exclude:Brain MRI, Spine MRI, or Abdominal MRI where the breast is incidental and compressed

    Coil & Field of View (BREAST FOCUS): • Breast coil geometry:bilateral breasts hanging in the coil, or a dedicated sagittal/axial single-breast view. • Exclude:Brain MRI, Spine MRI, or Abdominal MRI where the breast is incidental and compressed. •FOV:must include the axillary tail region

  17. [17]

    • Cardiac motion artefacts:check the left-breast phase- encoding direction; severe pulsation rendering the medial breast unreadable→Invalid

    Sequence & Physics: • Fat Saturation:CRITICALfor breast – fat must be sup- pressed (dark) except in T1 non-fat-sat anatomy scans. • Cardiac motion artefacts:check the left-breast phase- encoding direction; severe pulsation rendering the medial breast unreadable→Invalid. • Silicone select:for implant cases, confirm silicone- specific sequences are used

  18. [18]

    enhancement kinetics

    Text–Image Alignment:text describes “enhancement kinetics”, “BPE”, or “washout”; flag mismatch if it describes CT density. Output JSON:{validity, reason}. Side-Aware Report Splitter You are anexpert breast radiologist. Process Chinese radiology reports: (1) split findings by side, (2) translate everything into professional medical English, (3) determine b...